Published on 5/8/2009 in the Prospect News PIPE Daily.
New Issue: Yongye Biotechnology International wraps $8.98 million private placement of shares
By Devika Patel
Knoxville, Tenn., May 8 - Yongye Biotechnology International, Inc. completed an $8.98 million private placement of stock, according to an 8-K filed Friday with the Securities and Exchange Commission.
The company sold 5,834,083 common shares at $1.54 per share.
ROTH Capital Partners, LLC was the agent.
With headquarters in Beijing and a manufacturing plant in Hohhot, Inner Mongolia, Yongye is engaged in the research, development, production and sales of fulvic acid based liquid and powder nutrient compounds used in the agriculture industry.
| Issuer: | Yongye Biotechnology International, Inc.
|
| Issue: | Common stock
|
| Amount: | $8,984,487.82
|
| Shares: | 5,834,083
|
| Price: | $1.54
|
| Warrants: | No
|
| Agent: | ROTH Capital Partners, LLC
|
| Settlement date: | May 8
|
| Stock symbol: | OTCBB: YGYB
|
| Stock price: | $1.85 at close Sept. 10
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
